Athira Pharma Inc.

ATHA | NASDAQ

Price Alert Chart Builder DCF Calculator

$6.75

-$0.44 (-6.12%)

At close: Jan 09, 2026, 04:00 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

-6.12%

(1Y)

Rating

Updated: Sep 22, 2026

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $26.62M

1D Range

6.61 7.35

52W Range

2.20 8.36

Valuation (TTM)

PE -0.29

PB 0.79

EV/EBITDA 1.18

Valuation (NTM)

Forward PE N/A

Forward PEG 0.00

Price Target $13.33

Cash Flow

FCF Yield -232.6%

SBC Adj. FCF Yield -257.8%

SBC Impact -10.8%

Margins

Gross Margin 0.0%

Operating Margin 0.0%

FCF Margin N/A

Growth (CAGR)

Revenue 3Y | 5Y N/A | N/A

Dil EPS 3Y | 5Y 14.6% | 1.7%

FCF 3Y | 5Y 23.7% | 3.3%

Returns

ROA -248.6%

ROE -411.6%

ROIC -246.3%

Financial Health

Net Cash

$50.49M

Current Ratio 7.01

Interest Coverage 0.00

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

No news articles available yet.